Shares of Thermo Fisher Scientific Inc. TMO inched 0.84% higher to $534.42 Tuesday, on what proved to be an all-around mixed ...

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 ...

Thermo Fisher Scientific (NYSE:TMO) has completed the repurchase of $1B (1.9M shares) of its common stock. As of Dec. 3, 2024, $3B remained available under the company’s share repurchase authorization ...

Thermo Fisher (TMO) announced that it has completed the repurchase of $1B of its common stock. As of December 3, $3B remained available under ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for ...

Diagnostics is pleased to announce the completion of a €30 million Series D funding round, led by Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science. This investment will ...

On Wednesday, Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $521.66 which represents a slight increase of $8.68 or 1.69% from the prior close of $512.98. The stock ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.14% of ...

Mines Biomed, a molecular genetics diagnostic company, has entered into a collaborative agreement with Thermo Fisher ...

Intech Investment Management LLC increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) ...

Thermo Fisher has launched a suite of expanded CRO and CDMO services under its own brand, Accelerator™ Drug Development, intended to serve biotechs and pharmas.